Other Species / Isoforms
  PLB (dog)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K3
_____MDKVQYLTRS
1 1
PLB (human) _____MEKVQYLTRS K3
PLB (mouse) _____MEkVQYLTRS K3-ub
PLB (rat) _____MEKVQYLTRS K3
PLB (rabbit) _____MEKVQYLTRS K3
PLB (pig) _____MDKVQYLTRS K3
PLB (dog) _____MDKVQYLTRS K3
K3
_____MDKVQYLTRS
0 1
PLB (human) _____MEKVQYLTRS K3
PLB (mouse) _____MEKVQYLTRS K3
PLB (rat) _____MEkVQYLTRS K3-ac
PLB (rabbit) _____MEKVQYLTRS K3
PLB (pig) _____MDKVQYLTRS K3
PLB (dog) _____MDKVQYLTRS K3
S16-p
RSAIRRAstIEMPQQ
Upstream
Downstream
60 81
PLB (human)
S16-p
PLB (mouse)
S16-p
PLB (rat)
S16-p
PLB (rabbit)
S16-p
PLB (pig)
S16-p
PLB (dog)
S16-p
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CAMK2A (human)
  • PKACA (dog)
  • PKACA (human)
Treatment
  • heart failure
PLB (human) RSAIRRAstIEMPQQ S16-p
PLB (mouse) RSAIRRAstIEMPQQ S16-p
PLB (rat) RSAIRRAstIEMPQQ S16-p
PLB (rabbit) RSAIRRAstIEMPQQ S16-p
PLB (pig) RSAIRRAsTIEMPQQ S16-p
PLB (dog) RSAIRRAstIEMPQQ S16-p
S16
RSAIRRAStIEMPQQ
1 0
PLB (human) RSAIRRAStIEMPQQ S16
PLB (mouse) RSAIRRAStIEMPQQ S16
PLB (rat) RSAIRRAstIEMPQQ S16-gl
PLB (rabbit) RSAIRRAStIEMPQQ S16
PLB (pig) RSAIRRASTIEMPQQ S16
PLB (dog) RSAIRRAStIEMPQQ S16
T17-p
SAIRRAstIEMPQQA
Upstream
59 75
PLB (human)
T17-p
PLB (mouse)
T17-p
PLB (rat)
T17-p
PLB (rabbit)
T17-p
PLB (pig)
T17-p
PLB (dog)
T17-p
Kinase, in vitro:
  • CAMK2A (human)
  • PKACA (dog)
Treatment
  • heart failure
PLB (human) SAIRRAstIEMPQQA T17-p
PLB (mouse) SAIRRAstIEMPQQA T17-p
PLB (rat) SAIRRAstIEMPQQA T17-p
PLB (rabbit) SAIRRAstIEMPQQA T17-p
PLB (pig) SAIRRAsTIEMPQQA T17
PLB (dog) SAIRRAstIEMPQQA T17-p